Human T regulatory cells can use the perforin pathway to cause autologous target cell death

被引:809
作者
Grossman, WJ
Verbsky, JW
Barchet, W
Colonna, M
Atkinson, JP
Ley, TJ [1 ]
机构
[1] Washington Univ, Sch Med, Siteman canc Ctr, Dept Genet,Dept Internal Med, St Louis, MO 63110 USA
[2] St Louis Childrens Hosp, Dept Pediat, Div Hematol Oncol, St Louis, MO 63110 USA
[3] St Louis Childrens Hosp, Dept Pediat, Div Rheumatol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA
关键词
D O I
10.1016/j.immuni.2004.09.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg sub-types display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.
引用
收藏
页码:589 / 601
页数:13
相关论文
共 61 条
[1]  
Allen M, 2001, HAEMATOLOGICA, V86, P499
[2]   Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance [J].
Antov, A ;
Yang, L ;
Vig, M ;
Baltimore, D ;
Van Parijs, L .
JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3435-3441
[3]   Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene [J].
Arico, M ;
Imashuku, S ;
Clementi, R ;
Hibi, S ;
Teramura, T ;
Danesino, C ;
Haber, DA ;
Nichols, KE .
BLOOD, 2001, 97 (04) :1131-1133
[4]  
ATKINSON JP, 1994, CLIN EXP IMMUNOL, V2, P1
[5]   Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice [J].
Badovinac, VP ;
Hamilton, SE ;
Harty, JT .
IMMUNITY, 2003, 18 (04) :463-474
[6]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[7]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[8]  
Bird P I, 1998, Results Probl Cell Differ, V24, P63
[9]   The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites [J].
Bladergroen, BA ;
Strik, MCM ;
Bovenschen, N ;
van Berkum, O ;
Scheffer, GL ;
Meijer, CJLM ;
Hack, CE ;
Kummer, JA .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3218-3225
[10]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257